earnings
OK
NASDAQ · OKUR
OnKure Therapeutics, Inc.
Healthcare · Biotechnology
$2.93
Down-$0.07 (-2.33%)
Updated Sep 16, 2026, 10:34 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.44M
- P/E ratio
- -6.67
- Dividend yield
- 0.00%
- 52-week range
- $2.23 – $5.38
- Volume
- 171.1K
- Avg. volume
- 131.89K
Price performance
OKUR price history
1M range · 20 trading sessions · Daily adjusted prices
OKUR closed at $2.93 after 20 trading sessions, down 30.40% for the selected period.
- Last close
- $2.93
- Period change
- -30.40%
- Period low
- $2.93
- Period high
- $4.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.98 | $2.98 | $2.815 | $2.93 | 171.1K |
| Sep 14, 2026 | $3.11 | $3.14 | $2.978 | $3.00 | 105.16K |
| Sep 11, 2026 | $3.31 | $3.33 | $2.98 | $3.10 | 253.65K |
| Sep 10, 2026 | $3.36 | $3.42 | $3.24 | $3.27 | 168.52K |
| Sep 9, 2026 | $3.38 | $3.4899 | $3.319 | $3.38 | 80.09K |
| Sep 8, 2026 | $3.55 | $3.90 | $3.34 | $3.40 | 115.01K |
| Sep 4, 2026 | $3.53 | $3.62 | $3.5075 | $3.58 | 165.54K |
| Sep 3, 2026 | $3.56 | $3.62 | $3.52 | $3.56 | 132.19K |
| Sep 2, 2026 | $3.54 | $3.665 | $3.41 | $3.54 | 127.42K |
| Sep 1, 2026 | $3.62 | $3.70 | $3.4935 | $3.56 | 193.56K |
| Aug 31, 2026 | $3.80 | $3.8999 | $3.54 | $3.63 | 100.48K |
| Aug 28, 2026 | $3.83 | $4.02 | $3.67 | $3.79 | 432.47K |
| Aug 27, 2026 | $3.77 | $3.86 | $3.77 | $3.83 | 97.73K |
| Aug 26, 2026 | $3.86 | $4.0126 | $3.70 | $3.80 | 80.36K |
| Aug 25, 2026 | $3.91 | $4.043 | $3.79 | $3.85 | 116.23K |
| Aug 24, 2026 | $3.95 | $4.39 | $3.70 | $3.89 | 421.07K |
| Aug 21, 2026 | $3.95 | $4.0728 | $3.90 | $3.94 | 59.91K |
| Aug 20, 2026 | $4.04 | $4.043 | $3.78 | $3.93 | 103.52K |
| Aug 19, 2026 | $4.29 | $4.42 | $4.07 | $4.08 | 166.17K |
| Aug 18, 2026 | $4.11 | $4.27 | $3.99 | $4.21 | 108.17K |
Latest OKUR news
The latest Smart Investors Daily articles mentioning OKUR.
Stock researchCompany · Overview
OKUR research
Overview
Company profile and research snapshot.
Company profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $35.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | Oppenheimer | Outperform | — |
| Jul 20, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 16, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 26, 2025 | HC Wainwright & Co. | Buy | — |
| Mar 18, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.